Copyright Clearance Center

OCTOBER 19, 2022

The post Transition to Open Access: Tackling Complexity and Building Trust appeared first on Copyright Clearance Center.

98

98

Copyright Clearance Center

NOVEMBER 9, 2022

The post Exploring the Challenges in the Shift to Open Access: Part 2 – Pricing appeared first on Copyright Clearance Center.

97

97

Copyright Clearance Center

NOVEMBER 30, 2022

The post Exploring Challenges in the Shift to Open Access: Part 3 – Communication and Collaboration appeared first on Copyright Clearance Center.

92

92

Copyright Clearance Center

OCTOBER 4, 2022

The post Missing Revenue in the Global Flip: Getting the Open Access Math Right appeared first on Copyright Clearance Center.

98

98

Copyright Clearance Center

SEPTEMBER 29, 2022

The post Missing Revenue in the Global Flip: Getting the Open Access Math Right appeared first on Copyright Clearance Center.

98

98

pharmaphorum

NOVEMBER 1, 2022

When Plaid effectively forced financial institutions to take an open-protocol approach to digital interoperability, “Every bank (took) their five-year strategy on digitizing and brought it down into one or two years,” CEO Zach Perret said in an interview with Fortune magazine. You may ask: Can an open protocol be HIPAA compliant?

Patients 97

Patients Electronics Healthcare Healthcare 97

Copyright Clearance Center

FEBRUARY 14, 2023

The post The American Society for Microbiology Adopts CCC RightsLink for Scientific Communications to Manage its Growing Open Access Program appeared first on Copyright Clearance Center.

Management 96

Management 96

Copyright Clearance Center

SEPTEMBER 13, 2022

The post The Art of the Deal: How Data Quality Makes or Breaks Open Access Agreements appeared first on Copyright Clearance Center.

98

98

Copyright Clearance Center

JULY 18, 2023

CCC , the leading provider of Open Access (OA) workflow solutions, announces an enhancement to the processing of OA Agreements for university library consortia in its innovative scholarly communications workflow solution for the OA community, RightsLink for Scientific Communications (RLSC). July 18, 2023 – Danvers, Mass. –

Media 98

Media Management Marketing Leads 98

Copyright Clearance Center

DECEMBER 1, 2022

The post The Value of Open Access in XML Format? appeared first on Copyright Clearance Center.

75

75

Copyright Clearance Center

SEPTEMBER 8, 2022

The post Exploring the Challenges in the Shift to Open Access: Part 1 – Data appeared first on Copyright Clearance Center.

75

75

Copyright Clearance Center

JANUARY 17, 2023

CCC , a leading provider of Open Access (OA) workflow solutions, announces the American Society for Microbiology (ASM), has adopted RightsLink for Scientific Communications (RLSC) to manage its growing OA program. January 17, 2023 – Danvers, Mass. –

Management 52

Management Government Education Training 52

Copyright Clearance Center

OCTOBER 12, 2023

CCC added new data import capabilities and AI-enabled affiliation matching in its OA Agreement Intelligence modeling and analytics tool that provides publishers with a 360-degree view of disambiguated publication data to build accurate, transparent institutional offers regarding OA.

52

52

Copyright Clearance Center

APRIL 16, 2024

In a publishing environment buffeted by digital disruption and calls for open access, university presses in 2024 must manage to remain relevant and sustainable even as their audiences grow.

Management 98

Management 98

Pharmaceutical Commerce

NOVEMBER 14, 2023

Stem Cell Reports takes a look at DTC online advertising claims that these are ‘immune boosters.’

52

52

pharmaphorum

JANUARY 7, 2024

Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound, opening up a new direct-to-consumer (DTC) channel that

83

83

European Pharmaceutical Review

JANUARY 11, 2024

Ustekinumab biologic Once the European Supplementary Protection Certificate (SPC) for Stelara expires in July 2024, this will open up market entry as soon as possible for Uzpruvo, now that it is approved in Europe” Ustekinumab is a human IgG1κ monoclonal antibody (mAb). The EU ustekinumab market is worth €2.5

Competition 105

Competition Marketing Safety Manufacturing 105

Pharmaceutical Commerce

MARCH 19, 2024

Conference’s opening session addresses the evolving landscape of healthcare coverage and accessibility.

Healthcare 52

Healthcare Healthcare 52

MedCity News

OCTOBER 19, 2022

It will use the money to open more clinics throughout the country, as well as find ways to make its price point more accessible. Prenuvo — a company that makes an MRI machine that performs quick whole-body scans — closed a $70 million Series A equity and debt funding round.

Medical 122

Medical 122

Copyright Clearance Center

SEPTEMBER 12, 2023

CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, today announced Gold Open Access (OA) publisher Frontiers has adopted the industry-leading Ringgold Identify Database as its Persistent Identifier (PID) solution to help power its OA models by normalizing and disambiguating organization data.

Leads 114

Leads Management Marketing 114

MedCity News

FEBRUARY 28, 2023

UNC Health has partnered with the North Carolina Department of Health and Human Services to open a new inpatient psychiatric hospital for children and adolescents.

Healthcare 98

Healthcare Healthcare 98

European Pharmaceutical Review

JANUARY 4, 2024

The paper, published in the New England Journal of Medicine , described that in the first-in-human study, the focused ultrasound system was able to safely and temporarily open the blood-brain barrier to allow the anti-amyloid-beta antibodies increased access to targeted areas of the brain.

Medicine 79

Medicine Leads Patients Pharmaceutical 79

Copyright Clearance Center

NOVEMBER 7, 2022

November 7, 2022, LEHI, Utah — CloudSource+ , the newest content solution for open access materials from SirsiDynix , has integrated with Get It Now from CCC (Copyright Clearance Center) to provide immediate purchase and delivery of full-text articles to unsubscribed journals. Stay within budget with advanced data and reporting.

Management 136

Management Sales 136

European Pharmaceutical Review

MARCH 10, 2023

Today marks the opening the NHS Blood and Transplant (NHSBT)’s new Clinical Biotechnology Centre (CBC) in Bristol. This inevitably delays clinical trials and patients’ access, and often increases costs. The state-of-the-art facility was part-funded by a £9.43

Manufacturing 132

Manufacturing Engineering Government Patients 132

Pharmacy Times

SEPTEMBER 7, 2023

The importance of findability, accessibility, interoperability, and reusability has become even more significant to academics as government agencies increasingly require data openness and accessibility for funding eligibility.

Government 52

Government 52

Clarivate

SEPTEMBER 7, 2023

Figure 3: Output – Trends in international output and open access output for 2013-2022 for each G20 member nation. United Kingdom’s shift in dissemination strategy : With over half of its output published in open access journals, the U.K. signifies a shift in research dissemination and partnership strategies.

Government 116

Government Education Medicine Medical 116

Medgadget

MAY 12, 2023

Researchers at Northwestern University have trailed an implanted ultrasound device in patients, which is used in combination with microbubbles to transiently open pores in the blood brain barrier, allowing chemo drugs to enter. This version of the technique actually involves implanting a grid of nine ultrasound emitters into the skull.

Specialization 109

Specialization Patients Medicine 109

European Pharmaceutical Review

JUNE 9, 2023

Telix Pharmaceuticals has opened a new radiopharma production facility in the Wallonia region of Belgium, which will serve as the company’s primary manufacturing site for radioisotopes and commercial and clinical products. The post Radiopharma production facility opens in Belgium appeared first on European Pharmaceutical Review.

Manufacturing 88

Manufacturing Transportation Government Pharmaceutical 88

Copyright Clearance Center

APRIL 18, 2023

In addition to Matt Cannon , Head of Open Research, Taylor & Francis , panelists include Daniel Shanahan , Publishing Director, PLOS and Dr José Francisco Salm Junior , PhD, Professor, UDESC-ULisbon. Christopher Kenneally , host of CCC’s award-winning Velocity of Content podcast, will moderate.

Government 98

Government Media Management Leads 98

European Pharmaceutical Review

JUNE 7, 2023

As its first facility in Scotland, the Cell and Gene Therapy Catapult (CGT Catapult) has opened new laboratories located in the Edinburgh BioQuarter, at the University of Edinburgh’s Institute of Regeneration and Repair. It is the UK’s first specifically designed accessible laboratory for the cell and gene therapy industry.

Medicine 94

Medicine Manufacturing Marketing Pharmaceutical 94

World of DTC Marketing

FEBRUARY 7, 2022

.” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales). On top of this, “the company also revealed that the Federal Trade Commission and the Securities and Exchange Commission had opened two new, separate investigations into the troubled biotech.

Marketing 253

Marketing Pharma Sales Management 253

Copyright Clearance Center

AUGUST 3, 2023

When it comes to successful Open Access initiatives, a critical element is high-quality metadata.

52

52

Pharma Marketing Network

OCTOBER 16, 2023

It means that companies must be open and honest in their communication with customers, and provide them with clear and accurate information. Additionally, transparency involves providing customers with access to the company’s records and information. Understanding Transparency Transparency is the key to building trust.

Marketing 52

Marketing Pharma Pharmaceutical Sales 52

European Pharmaceutical Review

MARCH 31, 2023

“The access to increased capital… could allow for the potential for biopharmaceutical companies to improve investment in the development of therapies.” However, the acquisition of Silicon Valley Bank UK by HSBC could provide greater access for biopharmaceutical startups to international markets and global networks of investors.

Biopharma 95

Biopharma Pharma Networking Marketing 95

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. In the past, researchers have often had to seek help from outside the UK, thus delaying clinical trials and patient access.

Manufacturing 105

Manufacturing Distribution Medicine Patients 105

pharmaphorum

JULY 26, 2022

Newly diagnosed cancer patients across the UK will get free access to digital mental health therapies, thanks to a new partnership between Macmillan Cancer Support and Big Health. All Scottish adults already have access to Sleepio and Daylight, under a partnership with NHS Scotland, it added. Photo by Yuris Alhumaydy on Unsplash.

Patients 130

Patients Management Medical 130

Copyright Clearance Center

AUGUST 9, 2022

RightFind provides immediate access to subscribed scientific, technical, and medical (STM) content. At the JAMA Network, we are interested in providing our readers the most seamless access to the research, opinion, and clinical educational content we publish,” said Vida Damijonaitis, JAMA Network Director of Worldwide Sales.

Networking 115

Networking Medicine Physicians Education 115